Search results for “Epithelial tumour” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 67 patents, we discovered top 15 key players by total patent application. Bionsil SRL, Centro de Ingenieria Genetica y Biotecnologia, Active Biotech AB are dominant in this area. They take 49.25% of the total patent filing.
Bionsil SRL
Lombardia, Italy
Patent: 12
Centro de Ingenieria Genetica y Biotecnologia
HAVANA, Cuba
Patent: 12
Active Biotech AB
Sweden
Patent: 9
Europroteome AG
Brandenburg, Germany
Patent: 4
Scotgen Biopharmaceuticals, Inc.
United States
Patent: 4
Roussel UCLAF
undefined undefined
Patent: 3
Proteome Sciences Plc
United Kingdom
Patent: 2
Hoechst Marion Roussel, Inc.
Missouri, United States
Patent: 2
Sarossa Capital Ltd.
United Kingdom
Patent: 2
Corion Biotech Srl
Piemonte, Italy
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
No data, please try another search term
New Entrants
Order by:
Innovation in recent 5 years
No data, please try another search term
Research Institutions
Order by:
Innovation Intensity
With the analysis among 22 patents, we discovered top 2 universities and scientific research institutions by total patent application.
Consejo Superior de Investigaciones Científicas
Madrid, Spain
Patent: 6
The Garvan Institute of Medical Research
New South Wales, Australia
Patent: 4
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: